High concentrations of a heart-related protein in pregnant women with PAH show those at a high risk of complications after ...

Most PAH patients who completed one year in a CS1 expanded access program had stable or improved clinical measures.

Reflecting on this year's PHA conference in Dallas, columnist Mike Naple writes that connecting with community can be the ...

[vc_row][vc_column][vc_column_text]Pulmonary hypertension (PH) is a rare but severe disease characterized by high blood pressure in the lungs. The disease affects the pulmonary arteries, which are ...

A study linked elevated blood levels of uric acid, a metabolic breakdown product often associated with gout, to a higher risk ...

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...

Corsair Pharma‘s experimental skin-worn patch designed to deliver treprostinil, an approved treatment for pulmonary arterial hypertension (PAH), appears to be working as intended, according to newly ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Corvista Health will collaborate with Mayo Clinic to evaluate ...

Pulmonary hypertension (PH) is a rare but severe health condition characterized by high blood pressure in the pulmonary arteries. It is diagnosed when the arteries that transport blood from the heart ...

Balloon pulmonary angioplasty (BPA) led to significant clinical improvements for people with chronic thromboembolic pulmonary hypertension (CTEPH) when used as an initial therapy or after a pulmonary ...

What is Yutrepia for pulmonary hypertension? Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil that’s approved in the U.S. to improve exercise capacity in people with ...